Skip to content
Live funding
Sesame Summit 2027
Sesamers
Agrifood family · Vertical

Foodtech in Europe

The complete Sesamers guide to European food and agritech: the value chain mapped, where capital went, who is building and funding it, the three questions the sector cannot agree on, and how to get in.

Pillar page · 16 sections · last reviewed 21 Sep 2026 · desks refresh weekly
195 Companies tracked
10 Active investors
198 Rounds tracked
6 Events assessed
12 Sub-verticals

What counts as foodtech here

Any company applying technology to how food is grown, processed, moved, sold or recovered – from soil biologicals through fermentation and processing equipment to waste valorisation. We include upstream agritech and exclude restaurant software, delivery marketplaces and grocery retail, which are consumer marketplaces wearing a food label.

Family
Agrifood
Sub-verticals
12
Coverage since
2019
Desks
4

The four desks

Each one is a live page – this pillar is the way in

The value chain, mapped

Six stages · capacity bars show where European capital concentrates

The 12 sub-verticals

Filter the startup desk by any of these

Where the money went

Disclosed equity only – grants and debt excluded – source: the deals desk

European foodtech funding by year €M
€410M 2019
€520M 2020
€1.24B 2021
€980M 2022
€610M 2023
€540M 2024
€690M 2025
By category, last 24 months €M
Ag inputs & biologicals €280M
Supply chain €245M
Alternative protein €210M
Precision fermentation €165M
Farm robotics €140M
Controlled-environment ag €95M
Circularity €80M
Other €205M

Where the companies are

Headquarters counted on the startup desk

Where the sector stands

Three eras, not a straight line

2021-22
The peak, and the first cracks

Record deployment into alternative protein at valuations set on narrative. Two of the largest European rounds of the period have since been written down.

2023-24
The correction

Down rounds, quiet shutdowns, and six sector conferences folding. Generalist funds left; specialists stayed and got pickier.

2025-26
The re-rating

Funding flat but diligence-heavy. Money concentrates in ag inputs, supply chain and processing – the parts with existing buyers.

Three open questions

Where informed people in this sector genuinely disagree

Can alternative protein ever reach commodity price?

The category raised on a cost curve that assumed scale would arrive by 2025. It did not, and the gap between production cost and the commodity it replaces is still measured in multiples rather than percentages.

The case forEvery industrial fermentation product in history followed the same curve, and this one is fifteen years in rather than fifty. Titre and yield improvements compound, feedstock costs are falling, and the first plants built at real scale have not finished their learning curve.
The case againstThe comparison is to commodity protein produced by an industry with a century of subsidy and infrastructure behind it. Even a tenfold drop leaves a gap the consumer will not pay for without a regulatory or climate shock that has not arrived.
Where we land: parity is the wrong target. The companies clearing rounds in 2026 sell into applications where the incumbent ingredient is already expensive – specialty proteins, functional ingredients – not commodity food.
Does controlled-environment agriculture ever pencil out?

Vertical farms raised on unit economics that assumed energy and labour would fall faster than they have. Several European operators have since restructured or closed.

The case forHigh-value crops, co-located offtake and renewable power change the model. The failures were lettuce-at-scale stories, not proof that enclosed systems cannot work for the right crop and buyer.
The case againstCapex and opex still dominate. Without cheap power and a crop that already sells at a premium, CEA is a science project wearing a P&L.
Where we land: both are right, about different businesses. CEA works as a specialist tool – propagation, pharma crops, seed production, island geographies – and does not work as an alternative to a field.
Is EU regulation a moat or a millstone?

Novel-food authorisation, labelling rules and farm-input approvals slow European founders relative to US peers – and also raise the bar for anyone copying them later.

The case forA cleared dossier is a barrier competitors cannot skip. Buyers and retailers trust the stamp, and the same process that costs a year also filters out weak science.
The case againstCapital and talent go where the clock is shorter. Founders relocate trials, raise on US timelines, and European plants wait while the category moves on.
Where we land: a moat if somebody else pays for it. The companies handling this well file early, fund the dossier with non-dilutive money, and build revenue in an unregulated adjacent product while they wait.

The novel-food path

Indicative stages for an EU novel-food authorisation – not legal advice

Stage 1 Pre-submission

Establish whether your product needs authorisation at all. Consultation with a member-state authority resolves the question and is cheap relative to guessing wrong.

3-6 months €15-40k
Stage 2 Dossier

Compositional, toxicological and allergenicity data assembled to EFSA's format. This is the real cost and the stage where most first-time applicants lose a year.

9-18 months €250k-1M
Stage 3 EFSA assessment

Nine-month statutory clock that pauses every time information is requested – and it is usually requested. Plan for the clock to stop at least once.

9-15 months Staff time
Stage 4 Authorisation

Commission and member states. Once listed, the product can be sold under the authorised conditions – the commercial work starts here, not ends.

3-6 months Launch

How to get in

Three audiences, three short lists

If you are building

  1. Identify which of the six chain stages you sell into – it determines your buyer, your cycle and your funder.nFind a paying customer before a plant. Every fund on the investor desk said this unprompted.nCheck the regulatory path at Stage 1 in your first six months, not your third year.nPick two events: one deal room, one buyer room.

If you are investing

  1. Start on the investor desk filtered to stage and ticket – not a conference badge scan.nUnderwrite buyer concentration and regulatory clock before TAM slides.nMeet operators who already sell into the chain stage you are writing about.nUse the funding desk to see who actually led rounds in the last 24 months.

If you are buying or partnering

  1. Map the chain stage you need, then the sub-vertical – not the buzzword.nPrefer companies with a named pilot or offtake over deck-stage claims.nUse events for discovery; use the startup desk for diligence lists.nAsk for titre, offtake and regulatory status in the first call.

Who to know

Start on the desks – profiles update as we verify them

Programmes worth a look

Accelerators and calls that recur for this vertical

Glossary

Terms that keep coming up on this vertical

Novel food
Any food not consumed significantly in the EU before May 1997. Requires authorisation before sale – the single biggest timeline risk in the sector.
Precision fermentation
Using engineered microbes to produce a specific molecule, usually a protein, rather than a whole biomass. Distinct from biomass fermentation.
Titre
Grams of target product per litre of fermentation broth. The number that determines whether a process is economic; ask for it before the TAM slide.
CEA
Controlled-environment agriculture – any enclosed growing system, from a glasshouse to a vertical farm. Not synonymous with vertical farming.
Biologicals
Crop inputs derived from living organisms or their products – microbes, extracts, peptides – rather than synthetic chemistry.
Offtake
A contracted buyer for future production. The document that turns a plant model into a bankable one.

Latest coverage

Reporting and analysis tagged to this vertical

All verticals, by family

Twelve families – each carries its own icon and accent token

Frequently asked

About this vertical and how we cover it

Is agritech the same vertical as foodtech?
Here, yes – they sit in one vertical inside the Agrifood family, because the capital, the events and increasingly the companies overlap. Upstream-only businesses are filed under the Ag inputs and Farm robotics sub-verticals so they can still be isolated.
Why is food delivery not included?
Because it is a consumer marketplace, not a food technology. Delivery, restaurant software and grocery retail are covered under Consumer & media, where the comparable companies actually are.
How often does this page change?
The numbers come from the four desks and move weekly. The written analysis is reviewed quarterly and the review date at the top is the honest one – if it is stale, the analysis is stale.
Why does the value-chain map weight inputs and supply chain so heavily?
Because that is where disclosed European equity has concentrated since the correction. The map is a capital map, not a moral ranking of which stage matters more.
Can I suggest a company or fund for the desks?
Yes. Use the suggest links on each desk. We verify before publishing; paid placement does not get you onto a ranking or directory.
How this page is maintained. Counts are generated from the four desks and refresh weekly. The written analysis is editorial and reviewed quarterly. Corrections and additions: contact the desk · editorial standards

The Circuit

Every event, round and deadline worth your calendar.

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.